Billionaire Shanghvi’s Sun Misses Profit Estimate on Ranbaxy

Updated on

Profit at Sun Pharmaceutical Industries Ltd., India’s largest drugmaker, missed analyst estimates as the cost of integrating Ranbaxy Laboratories Ltd. eroded margins.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.